| 000 | 01595 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516105639.0 | ||
| 264 | 0 | _c20130527 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1556-3871 | ||
| 024 | 7 |
_a10.1016/j.hrthm.2012.08.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLehrmann, Heiko | |
| 245 | 0 | 0 |
_a"Dormant transisthmus conduction" revealed by adenosine after cavotricuspid isthmus ablation. _h[electronic resource] |
| 260 |
_bHeart rhythm _cDec 2012 |
||
| 300 |
_a1942-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine _xadministration & dosage |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAtrial Flutter _xdrug therapy |
| 650 | 0 | 4 |
_aCatheter Ablation _xmethods |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
| 650 | 0 | 4 |
_aHeart Rate _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTricuspid Valve |
| 650 | 0 | 4 | _aVenae Cavae |
| 700 | 1 | _aWeber, Reinhold | |
| 700 | 1 | _aPark, Chan-il | |
| 700 | 1 | _aAllgeier, Jürgen | |
| 700 | 1 | _aSchiebeling-Römer, Jochen | |
| 700 | 1 | _aArentz, Thomas | |
| 700 | 1 | _aJadidi, Amir | |
| 773 | 0 |
_tHeart rhythm _gvol. 9 _gno. 12 _gp. 1942-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.hrthm.2012.08.020 _zAvailable from publisher's website |
| 999 |
_c22037684 _d22037684 |
||